Skip Navigation
Skip to contents

KDDW 2025


Speakers

Home    >    Program    >    Speakers

Member Societies

검색
  • * Bookmark: To add speakers to your Favorites, log in and click 'Star.' Your Favorites List can be found on My Page.

Symposium 01: Distinguished papers of 2024–2025 in Clinical and Molecular Hepatology
Nov. 13 (Thu), 09:00-10:35

  • The CMH journey: Global growth and author guidance Yeonjung Ha
    CHA University, Korea
    CV 즐겨찾기
  • CMH clinical research highlight–Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment Do Seon Song
    The Catholic University of Korea, Korea
    CV 즐겨찾기
  • CMH clinical trial highlight–Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial Yao-Chun Hsu
    I-Shou University, Taiwan
    CV 즐겨찾기
  • CMH epidemiologic research highlight–Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study Jeong-Hoon Lee
    Seoul National University, Korea
    CV 즐겨찾기
  • CMH multinational research highlight–Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306) Xiaolong Qi
    Southeast University, China
    CV 즐겨찾기

Presidential Lecture: Chung Yong Kim memorial lecture
Nov. 13 (Thu), 10:50-11:20

  • The liver odyssey: Four decades of progression and hope Joong-Won Park
    Myongji Hospital, Korea
    CV 즐겨찾기

Symposium 09: Special considerations for liver diseases in distinct conditions
Nov. 13 (Thu), 13:20-14:50

  • Risk-stratified prophylaxis for HBV reactivation in patients receiving biological agents Pin-Nan Cheng
    National Cheng Kung University, Taiwan
    CV 즐겨찾기
  • Management of anti-HBc or HBsAg-positive donors and recipients in liver transplantation Deok Gie Kim
    Yonsei University, Korea
    CV 즐겨찾기
  • Risks and benefits of statins and DOACs in cirrhotic patients with cardiovascular disease Ho Soo Chun
    Ewha Womans University, Korea
    CV 즐겨찾기
  • Current controversies in HCC risk and surveillance after SVR in HCV-infected patients Ryosuke Tateishi
    The University of Tokyo, Japan
    CV 즐겨찾기

Symposium 13: Big data in hepatology research: Sources and applications
Nov. 13 (Thu), 15:10-16:40

  • Korean nationwide population-based study using the National Health Information Database Han Ah Lee
    Chung-Ang University, Korea
    CV 즐겨찾기
  • Taiwanese nationwide database for chronic viral hepatitis Mei-Hsuan Lee
    National Yang Ming Chiao Tung University, Taiwan
    CV 즐겨찾기
  • Common data models for real-world data analysis Rae Woong Park
    Ajou University, Korea
    CV 즐겨찾기
  • Hepatocellular carcinoma in the setting of alcohol-related liver disease: insights from French prospective cohort studies Pierre Nahon
    Université Sorbonne Paris Nord, France
    CV 즐겨찾기

Symposium 17: Optimizing treatment strategies for HCC: Concurrent and sequential approaches
Nov. 14 (Fri), 08:30-10:00

  • The priority decision for subsequent systemic therapy after first-line failure of ICI-based regimens for HCC Arndt Vogel
    University of Toronto, Canada
    CV 즐겨찾기
  • Promising systemic agents for combination therapy with TACE and their mechanistic rationales in incurable HCC Sung Won Chung
    University of Ulsan, Korea
    CV 즐겨찾기
  • Role of radiotherapy for advanced-stage HCC in the era of IO Jeong Il Yu
    Sungkyunkwan University, Korea
    CV 즐겨찾기
  • Efficacy and safety of ICI-based treatment for Child-Pugh B HCC Jean-Charles Nault
    Université Sorbonne Paris Nord, France
    CV 즐겨찾기

Symposium 22: In vitro and in vivo experimental models to study liver diseases
Nov. 14 (Fri), 10:20-11:50

  • Models for hepatitis B and the associated liver cancers Kyun-Hwan Kim
    Sungkyunkwan University, Korea
    CV 즐겨찾기
  • Preclinical MASH studies Sang Geon Kim
    Dongguk University, Korea
    CV 즐겨찾기
  • Cancer immunotherapy research Tae-Jin Kim
    Korea Institute of Radiological & Medical Sciences, Korea
    CV 즐겨찾기

Symposium 27: Biomarkers for diagnosis, treatment response, and prognosis in liver diseases
Nov. 14 (Fri), 13:20-14:50

  • Early predictors of hepatitis B relapse after antiviral cessation Cheng-Hao Tseng
    I-Shou University, Taiwan
    CV 즐겨찾기
  • Biomarkers for monitoring disease progression in MASLD Nobuharu Tamaki
    Musashino Red Cross Hospital, Japan
    CV 즐겨찾기
  • Imaging markers predicting response to IO in HCC Subin Heo
    University of Ulsan, Korea
    CV 즐겨찾기
  • Histological markers for differential diagnosis of liver tumors and inflammatory conditions Haeryoung Kim
    Seoul National University, Korea
    CV 즐겨찾기

PG Course 04: Guidelines and evidence-based recommendations in liver disease management
Nov. 14 (Fri), 15:10-16:40

  • Chronic hepatitis B: Antiviral strategy Won-Mook Choi
    University of Ulsan, Korea
    CV 즐겨찾기
  • Chronic hepatitis C: Antiviral strategy Young Kul Jung
    Korea University, Korea
    CV 즐겨찾기
  • MASLD: Current and potential new treatments Won Sohn
    Sungkyunkwan University, Korea
    CV 즐겨찾기
  • Liver cirrhosis: Complications and specific management Do Seon Song
    The Catholic University of Korea, Korea
    CV 즐겨찾기

USG: Abdominal US training specialist 01
Nov. 15 (Sat), 08:30-10:00

  • Experiences and challenges in ultrasound education Tae Suk Kim
    Kangwon National University, Korea
    CV 즐겨찾기
  • Clinical practice guidelines for the managing pancreatic cystic neoplasm Yoonseok Lee
    Gachon University, Korea
    CV 즐겨찾기
  • CEUS LI-RADS for diagnosis of hepatocellular carcinoma Jae Seok Bae
    Seoul National University, Korea
    CV 즐겨찾기
  • Recent advances and future perspectives in spleen stiffness measurement Jeong-Ju Yoo
    Soonchunhyang University, Korea
    CV 즐겨찾기

USG: Abdominal US training beginner
Nov. 15 (Sat), 08:30-10:00

  • Scanning technique for the beginner: Liver Ji Won Park
    Hallym University, Korea
    CV 즐겨찾기
  • Scanning technique for the beginner: Pancreato-biliary Heechul Nam
    The Catholic University of Korea, Korea
    CV 즐겨찾기
  • Clinical approach for common abdominal US findings: Cystic liver disease & GB polyp Ji Eun Han
    Ajou University School of Medicine, Korea
    CV 즐겨찾기

USG: Abdominal US training specialist 02
Nov. 15 (Sat), 10:20-11:50

  • Noninvasive assessment of hepatic steatosis in MASLD era Tae Seop Lim
    Yonsei University, Korea
    CV 즐겨찾기
  • Advancements and future directions in elastography for portal hypertension Young Chang
    Soonchunhyang University, Korea
    CV 즐겨찾기
  • US guided percutaneous biopsy of abdominal viscera Jeong Woo Kim
    Korea University, Korea
    CV 즐겨찾기
  • Latest AI-powered ultrasound system (Focused on abdominal solution) Jun Sung Park
    Samsung Medison, Korea
    CV 즐겨찾기
-->
Supported by Member Societies
Associated Society
Supported by
Diamond
  • 대웅제약
Platinum
  • Innovate new and next
Gold
  • 동아st
  • 동올림푸스
Silver
Bronze
  • 한미약품
  • 한국로슈
  • 다케다
  • 에브비
  • 한국bms
  • 길라이드
  • 일동
  • 부광약품
  • 노보노딕스

Go to Top

KDDW Consortium (케이디디더블유 운영협의체)

Business License No.: 609-82-84671

President: Joo-Sung Kim

E-mail : kddwoffice@gmail.com

Address : 2F, 30, Bamgogae-ro 1-gil, Gangnam-gu, Seoul, 06349, Republic of Korea
KDDW 2025 Secretariat
Contact (Scientific Program & Abstract)
Email. kddwinfo@medioffice.or.kr / Tel. +82-10-2334-8265
(Registration & Sponsor)
Email. kddwconference@medioffice.or.kr / Tel. +82-2-459-8266